Cell · 2018 · 1.5K citations · 48 references
Life SciencesCancer BiologyImmunologyCancer ImmunologyTumor ImmunologyTumor MicroenvironmentImmune Cell InfiltrationImmune System ModelingT Cell Responses To TumorsTumor Immune MicroenvironmentTumor-associated MacrophagesTumor-infiltrating LymphocytesCancer OrganoidsModeling Tumor MicroenvironmentTumor Immunology ModelingTumor Microenvironment ModelingTumor Organoid Models
48
Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
Suzanne L. Topalian, F. Stephen Hodi, Julie R. Brahmer et al. · New England Journal of Medicine · 2012 · 12.7K citations · Full text
Life Sciences, Immunology, Oncology +17
Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer
H. Borghaei, L. Paz-Ares, Leora Horn et al. · New England Journal of Medicine · 2015 · 9.5K citations · Full text
Comprehensive molecular characterization of human colon and rectal cancer
Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer
Julie R. Brahmer, Karen L. Reckamp, Lucio Crinò et al. · New England Journal of Medicine · 2015 · 8.6K citations · Full text
Pharmacy, Oncology, Pharmacotherapy +15
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
Jordi Barretina, Giordano Caponigro, Nicolas Stransky et al. · Nature · 2012 · 8.5K citations
Medicine, Oncology, Pharmacology +15